Vardenafil is effective and well‐tolerated for treating erectile dysfunction in a broad population of men, irrespective of age
Open Access
- 20 December 2004
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 95 (1) , 110-116
Abstract
OBJECTIVES: To assess the efficacy and safety of vardenafil in the treatment of erectile dysfunction (ED) in men of different age groups. PATIENTS AND METHODS: In a retrospective pooled subgroup analysis of randomized, double‐blind, placebo‐controlled studies, men from the general population with ED received either placebo or vardenafil 5, 10 or 20 mg over 12 weeks. Efficacy variables included the erectile function (EF) domain score from The International Index of Erectile Function, diary response rates to questions on vaginal penetration and maintenance of erection, and positive responses to the Global Assessment Question (GAQ) ‘Has the treatment you have been taking over the past 4 weeks improved your erections?’. The 1385 men were grouped by age (P < 0.03 vardenafil 5 mg vs placebo, P < 0.001 vardenafil 10 and 20 mg vs placebo). The corresponding scores were 22 and 14 in men aged 45–64 years and up to 24 and 16 in those aged P < 0.03 vardenafil 5 mg vs placebo, P < 0.001 vardenafil 10 and 20 mg vs placebo). Vardenafil generated positive GAQ responses in ≈ 71%, 76% and 85% of men aged P ≤ 0.001 vardenafil vs placebo). The corresponding placebo rates were 23%, 25% and 34%. The most common treatment‐emergent adverse events were headache, rhinitis, flushing and dyspepsia, which were mild to moderate, transient and unrelated to age. CONCLUSION: Vardenafil is an effective and generally well‐tolerated treatment for ED, irrespective of age.Keywords
This publication has 35 references indexed in Scilit:
- Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic ProstatectomyJournal of Urology, 2003
- Prevalence of Erectile Dysfunction in France: Results of an Epidemiological Survey of a Representative Sample of 1004 MenEuropean Urology, 2002
- Community-based study of erectile dysfunction and sildenafil use: the Rancho Bernardo studyUrology, 2002
- Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activityUrology, 2001
- Correlates for Erectile and Ejaculatory Dysfunction in Older Dutch Men: A Community‐Based StudyJournal of the American Geriatrics Society, 2001
- Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’International Journal Of Impotence Research, 2000
- Sexual Function in 1,202 Aging Males: Differentiating AspectsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 1999
- Sexual Dysfunction in the United StatesJAMA, 1999
- Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging StudyJournal of Urology, 1994
- NIH Consensus Conference. Impotence. NIH Consensus Development Panel on ImpotenceJAMA, 1993